Guidance Capital’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,906
Closed -$263K 274
2025
Q4
$263K Buy
1,906
+19
+1% +$2.38K 0.06% 198
2025
Q3
$246K Buy
+1,887
New +$221K 0.06% 186
2025
Q2
Sell
-3,583
Closed -$322K 207
2025
Q1
$322K Sell
3,583
-59
-2% -$4.06K 0.1% 175
2024
Q4
$222K Buy
3,642
+1,284
+54% +$120K 0.07% 186
2024
Q3
$299K Buy
+2,358
New +$363K 0.09% 159

Other funds holding TMDX

Guidance Capital's TMDX Position: Q1 2026 in Review

Guidance Capital sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 1,906 shares — an estimated $263K sold.

Guidance Capital first reported a position in TMDX in Q3 2024 and held it in 5 quarters. The position peaked at $322K in Q1 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Guidance Capital reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Guidance Capital sold 1,906 Transmedics shares in Q1 2026, an estimated $263K.
  • Guidance Capital first reported a position in Transmedics in Q3 2024 and held it in 5 quarters.
  • Guidance Capital's Transmedics position peaked at $322K in Q1 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Guidance Capital's 13F filing for Q1 2026, filed 8 May 2026.